Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$5.81M Sell
273,976
-74,300
-21% -$1.25M 8.77% 1
2020
Q4
$4.6M Sell
348,276
-25,000
-7% -$270K 0.84% 38
2020
Q3
$3.29M Buy
373,276
+50,000
+15% +$494K 0.53% 42
2020
Q2
$3.23M Sell
323,276
-26,351
-8% -$285K 0.47% 43
2020
Q1
$2.57M Sell
349,627
-91,530
-21% -$893K 0.38% 48
2019
Q4
$3.43M Hold
441,157
0.26% 46
2019
Q3
$3.02M Hold
441,157
0.15% 49
2019
Q2
$2.81M Hold
441,157
0.11% 49
2019
Q1
$2.28M Hold
441,157
0.08% 50
2018
Q4
$1.63M Sell
441,157
-30,000
-6% -$99K 0.06% 54
2018
Q3
$1.37M Hold
471,157
0.04% 54
2018
Q2
$1.44M Hold
471,157
0.03% 53
2018
Q1
$1.45M Hold
471,157
0.03% 56
2017
Q4
$1.62M Buy
+471,157
New +$1.9M 0.03% 55

Other funds holding ICAD

Fairpointe Capital's ICAD Position: Q1 2021 in Review

Fairpointe Capital reduced its iCAD Inc (ICAD) stake by 21% in Q1 2021, selling an estimated $1.25M and leaving 273,976 shares worth $5.81M. The position accounts for 8.77% of the portfolio, ranked #1.

Fairpointe Capital first reported a position in ICAD in Q4 2017 and has held it in 14 quarters since. 87 funds tracked by Wall St. Rank hold ICAD as of Q1 2021.

  • Fairpointe Capital held 273,976 shares of iCAD Inc worth $5.81M as of Q1 2021.
  • Fairpointe Capital sold 74,300 iCAD Inc shares in Q1 2021, an estimated $1.25M.
  • iCAD Inc made up 8.77% of Fairpointe Capital's portfolio in Q1 2021, its #1 holding.
  • Fairpointe Capital first reported a position in iCAD Inc in Q4 2017 and has held it in 14 quarters since.
  • 87 funds tracked by Wall St. Rank held iCAD Inc as of Q1 2021.

Based on Fairpointe Capital's 13F filing for Q1 2021, filed 13 May 2021.